Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Inozyme Pharma Inc (NQ: INZY )

4.730 -0.320 (-6.34%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 29, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 195,843
Open 5.030
Bid (Size) 4.720 (6)
Ask (Size) 4.740 (4)
Prev. Close 5.050
Today's Range 4.615 - 5.360
52wk Range 3.150 - 19.58
Shares Outstanding 40,097,076
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Stocks That Hit 52-Week Lows On Friday
During Friday's trading, 69 companies set new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022
Upgrades 
Via Benzinga

Performance

YTD
-30.24%
-30.24%
1 Month
+28.18%
+28.18%
3 Month
+17.08%
+17.08%
6 Month
-31.94%
-31.94%
1 Year
-71.79%
-71.79%

More News

Read More
Inozyme Pharma Starts Dosing In INZ-701 Trial For Calcification Disorders
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Top Biotech Stocks: Trading Opportunities For Next Week - Sunday, May 22
Via Talk Markets
Why Inozyme Pharma Shares Are Jumping Today
Via Benzinga
2 Stocks Under $5 Insiders Are Aggressively Buying
Via Benzinga
60 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Nasdaq Down 200 Points; United Airlines Shares Jump
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Mid-Day Market Update: Nasdaq Turns Negative; US Weekly Jobless Claims Edge Lower
Via Benzinga
30 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Mid-Morning Market Update: Markets Open Higher; Tesla Beats Q1 Estimates
Via Benzinga
Executives Buy Around $5M Of 3 Penny Stocks
Via Benzinga
51 Biggest Movers From Thursday
Via Benzinga
51 Biggest Movers From Yesterday
Via Benzinga
35 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
68 Biggest Movers From Yesterday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 7, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
63 Biggest Movers From Friday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2021
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.